Dr. Prashant Kale

Senior Vice President – India BA/BE Operations

Dr. Prashant Kale brings an impressive 27 years of profound expertise in the analytical and bioanalytical domain, crowned with a Ph.D. in Chemistry and an MBA degree. As a distinguished academic, he boasts numerous publications to his credit. Dr. Kale has been an integral part of the Lambda family for over 19 years, following a noteworthy tenure with SGS India Ltd.

Currently serving as the Senior Vice President – BE Operations at Lambda Therapeutic Research, Dr. Kale orchestrates the technical and administrative functions of the Bioequivalence (BE) unit across Ahmedabad, Mehsana, and Mumbai, India. Dr. Kale’s purview extends to the bioanalytical laboratory in Toronto, Canada. With a wealth of experience, he has successfully navigated regulatory audits and inspections from renowned bodies such as DCGI, USFDA, ANVISA, Health Canada, UK MHRA, Turkey MoH, and WHO, showcasing his commitment to excellence and adherence to international standards. 

"Lambda & Novum's Clinical & Bioanalytical capabilities are globally recognized, with our rich regulatory track record standing as a testament to our research excellence."

Dr. Prashant Kale brings an impressive 27 years of profound expertise in the analytical and bioanalytical domain, crowned with a Ph.D. in Chemistry and an MBA degree. As a distinguished academic, he boasts numerous publications to his credit. Dr. Kale has been an integral part of the Lambda family for over 19 years, following a noteworthy tenure with SGS India Ltd.

Currently serving as the Senior Vice President – BE Operations at Lambda Therapeutic Research, Dr. Kale orchestrates the technical and administrative functions of the Bioequivalence (BE) unit across Ahmedabad, Mehsana, and Mumbai, India. Dr. Kale’s purview extends to the bioanalytical laboratory in Toronto, Canada. With a wealth of experience, he has successfully navigated regulatory audits and inspections from renowned bodies such as DCGI, USFDA, ANVISA, Health Canada, UK MHRA, Turkey MoH, and WHO, showcasing his commitment to excellence and adherence to international standards. 

"Lambda & Novum's Clinical & Bioanalytical capabilities are globally recognized, with our rich regulatory track record standing as a testament to our research excellence."